Aditya Birla Sun Life Pharma and Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹845 Cr | ₹1309 Cr |
Min Investment | ₹1000 | ₹5000 |
Min SIP Invesment | ₹100 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 10 Jul 2019 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 31% | 26.49% |
Expense Ratio | 2.27 | 2.14 |
Manager | Dhaval Joshi | Meeta Shetty |
ISIN Code | INF209KB1N91 | INF277K016A9 |
Exits Load | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 1.1% | 1.07% |
6 Month | 11.8% | 12.87% |
1 Year | -3.21% | -1.47% |
3 Year | 22.11% | 23.49% |
5 Year | 16.59% | 19.42% |
SIP Return Analysis
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 3.66% | 3.9% |
1 Year | 8.33% | 9.27% |
3 Year | 20.93% | 22.51% |
5 Year | 17.28% | 19.09% |
Rolling Lumpsum Returns
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 25.47% | 10.55% |
3 Year | 16.83% | 18.34% |
5 Year | 22.98% | 15.18% |
Risk Management
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 15.89% | 15.94% |
Sharp | 0.92% | 0.99% |
Beta | 0.96% | 0.98% |
Alpha | -0.92% | -0.12% |
Fund Managers
Scheme Name | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Dhaval Joshi | Meeta Shetty |
Total AUM | ₹361932 Cr | ₹17847 Cr |
Funds Managed | 55 | 5 |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 5 | 8.59 |
Mid Cap | 41.99 | 32.96 |
Small Cap | 27.1 | 30.52 |
Large Cap | 25.91 | 27.92 |
Sector Allocation
Scheme Name |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.95 | 6.22 |
Healthcare | 97.23 | 91.69 |
Basic Materials | 0.82 | 0.46 |
Financial Services | - | 1.63 |
Top Comparisons
DSP Aggressive Hybrid Fund- Regular Plan - Growth
3Y Returns15.08%
Mirae Asset Aggressive Hybrid Fund -Regular Plan-Growth
3Y Returns12.84%
HDFC Income Fund - Growth Option
3Y Returns6.76%
Nippon India Medium to Long Duration Fund - Growth Plan - Growth Option
3Y Returns6.66%
ITI Arbitrage Fund Regular - Growth
3Y Returns6.42%
Aditya Birla Sun Life Arbitrage Fund - Regular Plan - Growth
3Y Returns6.98%
Invesco India Liquid Fund - Bonus Option
3Y Returns6.41%
Edelweiss Liquid Fund - Regular Plan - Growth Option
3Y Returns6.92%